

(Sharecast News) - Immunotherapies developer Scancell Holdings has entered into a collaboration agreement with Cobra Biologics to manufacture the firm...


UK EXECUTIVE CHANGE SUMMARY: Carr's Names Pelham To Replace CEO Davies


IN BRIEF: Seneca Growth Profits From Scancell, Omega Share Sales


Scancell Consortium Gets Innovate UK Funding For Covid Vaccine Trial


Scancell Raises GBP15 Million To Fund Covid-19 Vaccine Development


IN BRIEF: Scancell Secures GBP2 Million From Placing


IN BRIEF: Scancell To Raise GBP15 Million Via Share, Loan Note Issue


Scancell To Start Clinical Trial For Cancer Treatment In 2021